Companies / Industrials
PAYX
Paychex
Human Resource & Employment Services
Human Resource & Employment ServicesAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health81
Growth67
Profitability100
Cash generation100
Balance sheet59
Dilution control80
Key ratios and five-year financials
Latest quarter revenue YoY (2026-08-31)5.9%Revenue growth (FY)16.5%Revenue CAGR (3y)8.7%Gross margin73.4%Operating margin39.8%Net margin27.9%Free cash flow margin36.8%R&D / revenue—Stock comp / revenue1.5%Net debt / operating cash flow1.36xCurrent ratio1.26Diluted share count change-0.6%
| Fiscal year ending | FY 2022-05 | FY 2023-05 | FY 2024-05 | FY 2025-05 | FY 2026-05 |
|---|---|---|---|---|---|
| Revenue | $4.6B | $4.9B | $5.1B | $5.4B | $6.3B |
| Gross profit | $3.2B | $3.5B | $3.7B | $3.9B | $4.6B |
| Operating income | $1.8B | $2.0B | $2.2B | $2.2B | $2.5B |
| Net income | $1.4B | $1.6B | $1.7B | $1.7B | $1.8B |
| Operating cash flow | $1.6B | $1.7B | $1.9B | $1.9B | $2.6B |
| Capital expenditure | $134M | $143M | $161M | $192M | $235M |
| Free cash flow | $1.5B | $1.6B | $1.7B | $1.7B | $2.3B |
| Stock-based comp | $53M | $63M | $61M | $112M | $96M |
| Buybacks | $145M | $0 | $169M | $104M | $611M |
| Dividends | $1000M | $1.2B | $1.3B | $1.4B | $1.6B |
| Cash | $370M | $1.2B | $1.5B | $1.6B | $1.1B |
| Total debt | $806M | $808M | $817M | $5.4B | $4.6B |
| Equity | $3.1B | $3.5B | $3.8B | $4.1B | $3.7B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.